Document Detail

Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis.
MedLine Citation:
PMID:  7639584     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The authors test antibiotic strategies aimed at either mitigating bacterial translocation from the gut or delivering antibiotics specifically concentrated by the pancreas for prevention of early secondary infection after acute necrotizing pancreatitis. BACKGROUND: Infection currently is the principal cause of death after severe pancreatitis. The authors have shown that the risk of bacterial infection correlates directly with the degree of tissue injury in a rodent model of pancreatitis. Bacteria most likely arrive by translocation from the colon. METHODS: Severe acute necrotizing pancreatitis was induced in rats by a combination of low-dose controlled intraductal infusion of glycodeoxycholic acid superimposed on intravenous cerulein hyperstimulation. At 6 hours, animals were randomly allocated to five treatment groups: controls, selective gut decontamination (oral antibiotics and cefotaxime), oral antibiotics alone, cefotaxime alone, or imipenem. At 96 hours, surviving animals were killed for quantitative bacterial study of the cecum, pancreas, and kidney. RESULTS: The 96-hour mortality (35%) was unaffected by any treatment regimen. Cecal gram-negative bacteria were significantly reduced only by the oral antibiotics. Pancreatic infection was significantly reduced by full-gut decontamination and by imipenem, but not by oral antibiotics or by cefotaxime alone. Renal infection was reduced by both intravenous antibiotics. CONCLUSIONS: Early pancreatic infection after acute necrotizing pancreatitis can be reduced with a full-gut decontamination regimen or with an antibiotic concentrated by the pancreas (imipenem) but not by unconcentrated antibiotics of similar spectrum (cefotaxime) or by oral antibiotics alone. These findings suggest that 1) both direct bacterial translocation from the gut and hematogenous seeding interplay in pancreatic infection while hematogenous seeding is dominant at extrapancreatic sites and 2) imipenem may be useful in clinical pancreatitis.
T Foitzik; C Fernández-del Castillo; M J Ferraro; K Mithöfer; D W Rattner; A L Warshaw
Related Documents :
22370864 - Nanocrystalline silver dressing and subatmospheric pressure therapy following neoadjuva...
7639584 - Pathogenesis and prevention of early pancreatic infection in experimental acute necroti...
2386024 - Isolation of chlamydia trachomatis from the middle ear aspirates of otitis media.
23152844 - Il-12p40 deficiency leads to uncontrolled trypanosoma cruzi dissemination in the spinal...
19920774 - Fatal human herpesvirus-6 infection after renal transplantation.
20921824 - Effect of hbd2 genetically modified dermal multipotent stem cells on repair of infected...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of surgery     Volume:  222     ISSN:  0003-4932     ISO Abbreviation:  Ann. Surg.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-09-14     Completed Date:  1995-09-14     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0372354     Medline TA:  Ann Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  179-85     Citation Subset:  AIM; IM    
Department of Surgery, Massachusetts General Hospital, Boston, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Administration, Oral
Amphotericin B / administration & dosage,  therapeutic use
Bacteria / drug effects
Bacterial Infections / prevention & control*
Bacterial Physiological Phenomena
Cecal Diseases / microbiology,  prevention & control
Cefotaxime / administration & dosage,  therapeutic use
Colistin / administration & dosage,  therapeutic use
Disease Models, Animal
Drug Therapy, Combination / administration & dosage,  therapeutic use
Imipenem / administration & dosage,  therapeutic use
Injections, Intravenous
Kidney Diseases / microbiology,  prevention & control
Pancreas / microbiology
Pancreatic Diseases / microbiology*,  prevention & control*
Pancreatitis / complications*
Rats, Sprague-Dawley
Survival Rate
Tobramycin / administration & dosage,  therapeutic use
Reg. No./Substance:
1066-17-7/Colistin; 1397-89-3/Amphotericin B; 32986-56-4/Tobramycin; 63527-52-6/Cefotaxime; 74431-23-5/Imipenem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II rece...
Next Document:  Nitric oxide regulates basal but not capsaicin-, CGRP-, or bile salt-stimulated rabbit esophageal mu...